A booklet towards assistance ladies with knowledge disabilities towards appreciate what breast cancer is and the importance of breast mammography has been launched at the University of Ulster.
Produced via Dr Laurence Taggart, from Ulster’s School of Nursing, ‘My Boobs and Me!’ was styled towards herald breast perception for ladies with knowledge disabilities.
It consumes vocabulary and brightly coloured films towards depict the risk and protective factors of breast cancer, as well as consuming noticeable photos of the ride across hospital within obtaining a mammogram.
In an originally pilot project funded via the Breast Cancer Campaign within 2009, Dr Taggart’s innovation indicated that ladies with knowledge disabilities had complications within experience what breast cancer was and the importance of attending for a mammogram.
“As portion of a team of investigators analysing the women’s experience of breast cancer and breast perception, a lot of these ladies lacked a noticeable experience of what breast cancer was,” he said.
“Also a lot of these ladies did not clearly appreciate the procedure of obtaining a mammogram; these ladies expressed panic and embarrassment. The booklet enables the ladies towards benefit a fuller experience of what beast cancer is, the risk and protective factors, as well recounting the ride across obtaining the invitation letter towards attending for a mammogram within hospital.”
Dr Taggart worked with ladies with knowledge disabilities towards assistance him design the booklet. Compass Advocacy Network, a Ballymoney-based charity, also worked with the Ulster lecturer onto the project. The charity’s ambition is towards enable adults with knowledge disabilities.
“With subsidy knotted from the Breast Cancer Campaign, I caused this booklet. Hopefully it shall assistance ladies with knowledge disabilities towards acknowledge and appreciate the signs and symptoms of breast cancer better and cooperation them within their ride within obtaining the mammogram,” Dr Taggart said.
“The booklet shall also help relations carers, ceremonial carers working with ladies with knowledge disabilities, GP’s, tradition nurses, breast screening nurses, radiographers and else healthcare professionals within backing ladies with knowledge disabilities.”
Copies of the booklet shall be allocated towards everybody the breast screening units across Northern Ireland and the UK, as well as the settlement knowledge disability teams.
Monday, November 29, 2010
Saturday, November 27, 2010
Bone drug cuts breast cancer death rate
A drug designed to treat bone thinning has been found to prevent secondary tumours in women who have had breast cancer and to increase their survival rates.
The study of more than 1,000 women who had received surgery for primary breast cancer found that giving them the drug, bisphosphonate clodronate, for two years reduced the occurrence of bone cancer by 56 per cent.
The number of deaths from the original breast cancers was reduced by 23 per cent. The researchers also detected a trend towards a reduction in cancers of major organs although these findings were not statistically significant.
However, they could be important for other cancers that can lead to cancer in bones, including prostate cancer.
Prof Trevor Powles, head of the breast unit at the Royal Marsden Hospital, London, led the study. He said yesterday: "There were little or few side effects from the treatment.
"So much is now happening in breast cancer that is positive and I am very glad to be involved. Several other studies have already started following our findings."
He said that while the researchers had hoped to see a reduction in the occurrence of cancer of the bones, to which breast cancer commonly spreads, the reduction in the death rate was unexpected.
"The findings of this study are encouraging for breast cancer patients and may pave the way to more routine use of clodrinate or other bisphophonates in the prevention of bone metastases," he said.
Clodrinate, tradename, Bonefos, was first licensed in 1985 to treat bone thinning.
The women in the study, published in the Journal of Clinical Oncology this month, had all had surgery for primary breast cancer which had shown no sign of spreading to their bones. They were also being treated with chemotherapy and tamoxifen.
The study of more than 1,000 women who had received surgery for primary breast cancer found that giving them the drug, bisphosphonate clodronate, for two years reduced the occurrence of bone cancer by 56 per cent.
The number of deaths from the original breast cancers was reduced by 23 per cent. The researchers also detected a trend towards a reduction in cancers of major organs although these findings were not statistically significant.
However, they could be important for other cancers that can lead to cancer in bones, including prostate cancer.
Prof Trevor Powles, head of the breast unit at the Royal Marsden Hospital, London, led the study. He said yesterday: "There were little or few side effects from the treatment.
"So much is now happening in breast cancer that is positive and I am very glad to be involved. Several other studies have already started following our findings."
He said that while the researchers had hoped to see a reduction in the occurrence of cancer of the bones, to which breast cancer commonly spreads, the reduction in the death rate was unexpected.
"The findings of this study are encouraging for breast cancer patients and may pave the way to more routine use of clodrinate or other bisphophonates in the prevention of bone metastases," he said.
Clodrinate, tradename, Bonefos, was first licensed in 1985 to treat bone thinning.
The women in the study, published in the Journal of Clinical Oncology this month, had all had surgery for primary breast cancer which had shown no sign of spreading to their bones. They were also being treated with chemotherapy and tamoxifen.
Tuesday, November 9, 2010
Dutch doctors to kill breast cancer by using ultrasound heating
Carcinoma in situ in patients with early breast cancer after treatment, the cure rate of up to 98%. Licensed psychologists and other mental health professionals with experience in breast cancer treatment can help a great deal. In the early days, the application of radiotherapy in breast cancer treatment was mainly for the recurrent disease after mastectomy or for inoperable disease.
Dutch doctors will try to administer a new treatment to breast cancer patients in December by using ultrasound heating to kill tumor cells, the world’s first attempt of its kind. At present, Chinese scientists are studying the use of proteomics and gene analysis as a means to predict the sensitivity of breast cancer treatment, to develop individualized treatment targets.
Doctors will heat the breast tumors to a temperature of 60 to 90 degrees by using ultrasound technique, tumor cells die off and thus removed from the body, local press quoted sources from University Medical Center(UMC) of Utrecht as saying on Tuesday.
Sunday, November 7, 2010
curative time: chronic constipation may lead to risk of breast ca...
curative time: chronic constipation may lead to risk of breast ca...: "chronic constipation may lead to risk of breast cancerIn recent years, medical workers discovered that not only obesity, diet and genetics w..."
chronic constipation may lead to risk of breast cancer
chronic constipation may lead to risk of breast cancer
In recent years, medical workers discovered that not only obesity, diet and genetics will lead to women suffering from breast cancer，even Long-term chronic constipation Can also cause women to breast cancer.
The medical experts From the University of California has been testing milk and secretions for 1418 women. The results show that Stool once a day, 1 out of 20 women who developed abnormal breast cells, but less than 2 times per week were stool, 4 people will have an abnormal development of human breast cells.
Breast Cancer
Breast Cancer
What is breast cancer?
Breast cancer is the most common malignancy in women in most of countries. According to statistics, the incidence rate in population is 7-10% of various malignant tumors in the body. It’s often hereditary disease. And 40-60 years old, postmenopausal women before and after With a higher prevalence. Only about 1-2% of breast patients were male. It is a malignant tumor，usually begin to come on Glandular tissue in the breast. it is one of the most common malignant tumor, serious impact on women’s health and even life-threatening. Male breast cancer is rare.
Breast Cancer Symptoms
The main symptoms: breast masses, Nipple erosion, breast pain, Nipple Discharge, Axillary lymph nodes. As long as the majority of women can have stronger anti-cancer awareness, Fully understand and master the knowledge, Carefully work out self-examination, With medical care level, Believe that cancer is not incurable.
Early symptoms
1, Although some patients with early breast cancer have not been able to touch a clear mass in the breast department. but often feel discomfort in the Parts of the body, Especially postmenopausal women. Sometimes feel slight pain discomfort in the side of the breast, Soreness, Even in the side of the upper arm.
2, Lump can be felt by hand in the breast, It is hard, movable in early stages. Generally there is no considerable pain, a small number of Paroxysmal pain, dull pain or tingling.
3, changes in breast appearance: Visible tumor at the skin bulge, Some of the local orange peel-like, Or edema, discoloration, eczema-like changes and so on.
4, With nipple retraction near the center of the nipple.
5, nipple discharge: If the discharge was bloody, bloody serous should pay special attention for further examination.
6, Local lymph node enlargement, axillary lymph nodes is the most common on the same side. Lymph nodes in the supraclavicular were already late.
Subscribe to:
Posts (Atom)